The Vortex platform not only performed well in terms of high tumour cell recovery rates, but also across the full ... Read more

New investment to drive UK, Europe, and USA expansion EMV Capital (“EMVC”), the VC investor specialising in early-stage high-growth deep ... Read more

Our portfolio company Q-Bot recognised in the 2023 Robotics 50 List, which was derived from a combination of direct industry ... Read more

The Enterprise Investment Scheme (EIS) is a tax-efficient government-backed programme that offers incentives for investors to invest capital into qualifying ... Read more

The Enterprise Investment Scheme (EIS) offers investors a number of advantageous tax reliefs and allowances, encouraging investment into smaller, early-stage ... Read more

EMV Capital is a finalist at the prestigious Growth Investor Awards 2023 Now in its ninth year, the Growth Investor ... Read more

We don’t often think of anaesthetic gases as contributing to global warming, but 2 per cent of the UK NHS’s greenhouse gas ... Read more

Lord Callanan, the UK Energy Minister with responsibility for Energy Efficiency and Green Finance, has officially opened Q-Bot’s new head ... Read more

Improving performance is the aim. Our compact and lightweight design opens up the application space, making it perfect for mobile ... Read more

EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans.

The Enterprise Investment Scheme (EIS) offers generous tax advantages for investors – with the caveat that EIS shares or fund ... Read more

EMV Capital (“EMVC”), the VC investor specialising in early-stage high-growth deep tech companies, is delighted to announce that it has ... Read more

The Hull University Teaching Hospitals NHS Trust has awarded SageTech Medical the contract for waste volatile anaesthetic gas capture and ... Read more

EMV Capital, a venture capital (VC) platform backed by NetScientific plc, is looking to raise its debut thematic fund this ... Read more

SageTech Medical have worked closely with Draeger UK to provide NHS customers access to purchase our waste volatile anaesthetic gas capture ... Read more

EMV Capital (“EMVC”), the VC investor specialising in early-stage high-growth deep tech and life sciences companies, is delighted to announce ... Read more

The Enterprise Investment Scheme (EIS) is a government-backed initiative that provides tax incentives for investors contributing to early-stage and smaller ... Read more

Distribution Agreement with global hospital equipment leader Dräger; Sale to Manchester University NHS Foundation; and Med-Tech Innovation Sustainability Award EMV ... Read more

The agreement paves the way for Draeger UK’s NHS Supply Chain customers to purchase SageTech’s leading anaesthetic gas capture machine.

EMV Capital portfolio company Q-Bot, the robotics developer for construction retrofit, shortlisted for the Best EIS Investee company.